Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2272 Views
-
Last post by frodo
-
- 0 Replies
- 10408 Views
-
Last post by NHE
-
- 2 Replies
- 1657 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1868 Views
-
Last post by Petr75
-
- 0 Replies
- 1247 Views
-
Last post by NHE
-
- 2 Replies
- 1904 Views
-
Last post by frodo
-
- 0 Replies
- 11123 Views
-
Last post by NHE
-
- 0 Replies
- 2604 Views
-
Last post by frodo
-
- 0 Replies
- 2751 Views
-
Last post by NHE